photo montage

Technology & Operations Management

Science-Based Business Initiative Seminars

The Science-Based Business Initiative will sponsor a monthly lunch time seminar on Fridays and will bring academic and industry scientists to campus to describe some of the breakthrough ideas that impact current and future businesses. The intent an intimate group of faculty and doctoral students to gather in a seminar environment, Baker Library102, from noon to 1:30pm for a presentation and Q/A session.

Please RSVP no later than 72 hours prior to the seminar as lunch will be ordered for confirmed guests. To RSVP or for questions on a seminar or to join a mailing list, please contact sbbi@hbs.edu.

2006-2007 Speakers

9/15/06
Venkatesh Narayanamurti (Harvard)

The Genesis of the Information Revolution: The Interplay of Basic Research for Tomorrow’s Technology and the Changing Role of Research Universities in the 21st Century
10/20/06
Gregory Verdine (Harvard)

Behind the White Line: the Ins and Outs of Being an Academic Serial Entrepreneur
10/27/06
George Whitesides (Harvard)

Translating Science from the Academic Laboratory to the Market
11/03/06
Uma Chowdhry (DuPont)

DuPont: Two centuries of transformations
As DuPont enters its third century, it is useful to reflect upon what made DuPont successful and what were the key inventions as well as the science and technology structure & processes that allowed it to successfully grow and transform itself over 200 years. I will provide a brief overview of our history and speak about the key role that science and technology has played in the evolution of the company . The changing nature of global competition has required us to change the way we do science and technology today and I will describe the key changes we are making in our structure, processes and technologies as we look ahead to a sustainable future based on technology.
11/17/06
Mark Fishman (Novartis)

Pharma at the Frontier
02/02/07
Bob Higgins (Highland Capital)

Commercializing Science: The VC Perspective
02/09/07
Mark Pinto (Applied Materials)

Moore's Law and Nanomanufacturing: Cost-Focused Innovation and the Theory of Technology Overshoot
03/02/07
Phil Sharp (MIT)

Biotechnology: Its Origins and Future
03/09/07
Eric Lander (MIT/Harvard Medical School/Broad Institute)

Creating a Scientific Community: The Broad Institute of Harvard and MIT
03/30/07
Sue Desmond-Hellmann (Genentech)

Current and Future Trends in Biotechnology
*Monday seminar* 04/02/07
Alberto Vincentelli (Berkeley)

The Theory and Practice of Electronic Design
04/06/07
Ed Catmull (Pixar)

What Goes Wrong Behind the Block Buster Movies?
04/13/07
George Daley (Harvard Medical School)

The Business of Stem Cells
04/27/07
James Meindl (Georgia Tech)

Nanoelectronics: Retrospect and Prospect.
05/04/07
Peter Kim (Merck)

Innovation in the Pharmaceutical Industry
Peter S. Kim, Ph.D., 48, is a structural biologist known for discovering how proteins cause membranes to fuse, a central feature of all life. He has designed novel compounds that stop membrane fusion by the AIDS virus, thereby preventing it from infecting cells. Dr. Kim was appointed president of Merck & Co.'s Merck Research Laboratories (MRL) on January 1, 2003 and he is responsible for all of Merck's drug and vaccine discovery and development activities. Previously, Dr. Kim served as MRL's executive vice president, Research and Development, from February 1, 2001, to December 31, 2002. Prior to joining Merck, Dr. Kim was a Professor of Biology at Massachusetts Institute of Technology (MIT). He was also a Member of the Whitehead Institute and an Investigator of the Howard Hughes Medical Institute. Dr. Kim also served as a member of the National Institutes of Health (NIH) Advisory Committee to develop an AIDS vaccine. Dr. Kim received his undergraduate education at Cornell University, graduating with distinction in chemistry. He received his Ph.D. in biochemistry from Stanford University in 1985. While at Stanford, he was also a Medical Scientist Training Program Fellow. His work has earned him numerous awards including the National Academy of Sciences Award in Molecular Biology, the Eli Lilly Award in Biological Chemistry, the Hans Neurath Award of the Protein Society, and the Samsung Foundation Ho-Am Prize in Basic Science. Dr. Kim currently is a member of the Board of Directors of Fox Chase Cancer Center and the Whitehead Institute for Biomedical Research. He also serves as a member of the Council of the Institute of Medicine. Dr. Kim was elected a member of the National Academy of Sciences in 1997, and was elected a member of the Institute of Medicine in 2000.

Past Seminars